Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v15-EN | Version v12-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2021-09-08 | 2021-09-01 |
| Drug Identification Number | 02455935 | 02455935 |
| Brand name | INJECTABLE NALOXONE HYDROCHLORIDE | INJECTABLE NALOXONE HYDROCHLORIDE |
| Common or Proper name | Naloxone Hydrochloride Injection | Naloxone Hydrochloride Injection |
| Company Name | OMEGA LABORATORIES LIMITED | OMEGA LABORATORIES LIMITED |
| Ingredients | NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE |
| Strength(s) | 0.4MG | 0.4MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10 x 1mL vial / fiole | 10 x 1mL vial / fiole |
| ATC code | V03AB | V03AB |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2021-07-23 | 2021-07-23 |
| Estimated end date | 2021-10-08 | 2021-10-08 |
| Actual end date | 2021-09-07 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | High Demand on Market. On and Off Backorder. | High Demand on Market. On and Off Backorder. |
| Health Canada comments |